Maitreya Medicare (NSE:MAITREYA) Notes Receivable: ₹0.0 Mil (As of Sep. 2023)


NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
18 GF Score
Price ₹140.90
View Full Analysis

What is Maitreya Medicare Notes Receivable?

Maitreya Medicare NSE:MAITREYA 18 Notes Receivable is ₹0.0 Mil as of Sep. 2023. GuruFocus rates NSE:MAITREYA with a GF Score™ of 18/100.

Maitreya Medicare's Notes Receivable for the quarter that ended in Sep. 2023 was ₹0.0 Mil.

Maitreya Medicare Notes Receivable Related Terms

Maitreya Medicare Notes Receivable Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Notes Receivable Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23
Notes Receivable
0.00 0.00 0.00

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23
Notes Receivable 0.00 0.00 0.00 0.00
NSE:MAITREYA
18GF Score
Maitreya Medicare Ltd NSE:MAITREYA
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maitreya Medicare Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.0 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a Notes Receivable of ₹0.0 Mil as of Sep. 2023. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Maitreya Medicare and its competitors.
Is Maitreya Medicare's Notes Receivable too high?
Maitreya Medicare's current Notes Receivable is ₹0.0 Mil. Overall, Maitreya Medicare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Notes Receivable compare to HCA and DVA?
Maitreya Medicare's Notes Receivable of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Maitreya Medicare and its competitors. Maitreya Medicare's current Notes Receivable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current Notes Receivable of ₹0.0 Mil. The current Notes Receivable is ₹0.0 Mil. Maitreya Medicare's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Notes Receivable is ₹0.0 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
18GF Score

Get the complete analysis for NSE:MAITREYA

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹140.90
Price